Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

581 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study.
Pontillo G, Cocozza S, Lanzillo R, Borrelli P, De Rosa A, Brescia Morra V, Tedeschi E, Palma G. Pontillo G, et al. Among authors: de rosa a. Front Neurol. 2017 Jun 19;8:294. doi: 10.3389/fneur.2017.00294. eCollection 2017. Front Neurol. 2017. PMID: 28674518 Free PMC article.
Antiphospholipid-related chorea.
Peluso S, Antenora A, De Rosa A, Roca A, Maddaluno G, Brescia Morra V, De Michele G. Peluso S, et al. Among authors: de rosa a, de michele g. Front Neurol. 2012 Oct 22;3:150. doi: 10.3389/fneur.2012.00150. eCollection 2012. Front Neurol. 2012. PMID: 23097646 Free PMC article.
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease.
Picillo M, Amboni M, Erro R, Longo K, Vitale C, Moccia M, Pierro A, Santangelo G, De Rosa A, De Michele G, Santoro L, Orefice G, Barone P, Pellecchia MT. Picillo M, et al. Among authors: de rosa a, de michele g. J Neurol. 2013 Nov;260(11):2849-55. doi: 10.1007/s00415-013-7085-x. Epub 2013 Aug 30. J Neurol. 2013. PMID: 23989344
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression.
Moccia M, Lanzillo R, Palladino R, Chang KC, Costabile T, Russo C, De Rosa A, Carotenuto A, Saccà F, Maniscalco GT, Brescia Morra V. Moccia M, et al. Among authors: de rosa a. Mult Scler. 2016 Apr;22(5):659-67. doi: 10.1177/1352458515599075. Epub 2015 Sep 11. Mult Scler. 2016. PMID: 26362896
Mobitz type I and II atrioventricular blocks during fingolimod therapy.
Saccà F, Puorro G, Marsili A, Pane C, Russo CV, Lanzillo R, de Rosa A, Cittadini A, De Angelis G, Brescia Morra V. Saccà F, et al. Among authors: de rosa a, de angelis g. Neurol Sci. 2016 Sep;37(9):1557-9. doi: 10.1007/s10072-016-2621-y. Epub 2016 May 25. Neurol Sci. 2016. PMID: 27225279
The importance of being persistent to multiple sclerosis treatments.
Moccia M, Lanzillo R, Cerullo G, De Rosa A, Brescia Morra V. Moccia M, et al. Among authors: de rosa a. J Clin Neurosci. 2017 Jun;40:198-199. doi: 10.1016/j.jocn.2017.02.004. Epub 2017 Feb 27. J Clin Neurosci. 2017. PMID: 28246007 No abstract available.
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients.
Carotenuto A, Scalia G, Ausiello F, Moccia M, Russo CV, Saccà F, De Rosa A, Criscuolo C, Del Vecchio L, Brescia Morra V, Lanzillo R. Carotenuto A, et al. Among authors: de rosa a. J Neuroimmunol. 2017 Aug 15;309:47-50. doi: 10.1016/j.jneuroim.2017.05.006. Epub 2017 May 12. J Neuroimmunol. 2017. PMID: 28601287
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a.
Lanzillo R, Carbone F, Quarantelli M, Bruzzese D, Carotenuto A, De Rosa V, Colamatteo A, Micillo T, De Luca Picione C, Saccà F, De Rosa A, Moccia M, Brescia Morra V, Matarese G. Lanzillo R, et al. Among authors: de luca picione c, de rosa v, de rosa a. Clin Immunol. 2017 Oct;183:249-253. doi: 10.1016/j.clim.2017.08.011. Epub 2017 Aug 18. Clin Immunol. 2017. PMID: 28823971
581 results